Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patientsSanam Loghavi, Joseph D. Khoury, Tariq N. Aladily et al.|Journal of Hematology & Oncology|2015Cited by 139
RUNX3 is oncogenic in natural killer/T-cell lymphoma and is transcriptionally regulated by MYCViknesvaran Selvarajan, Siok‐Bian Ng|Leukemia|2017Cited by 71